<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Local contact(s)</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Michael</forename><surname>Sztucki</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Pharmaceutical Technology and Biopharmaceutics</orgName>
								<orgName type="institution">LMU München</orgName>
								<address>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ricarda</forename><surname>Nagel</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Pharmaceutical Technology and Biopharmaceutics</orgName>
								<orgName type="institution">LMU München</orgName>
								<address>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jonas</forename><surname>Binder</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Pharmaceutical Technology and Biopharmaceutics</orgName>
								<orgName type="institution">LMU München</orgName>
								<address>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>Prof</roleName><forename type="middle">Wolfgang</forename><surname>Frieß</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Pharmaceutical Technology and Biopharmaceutics</orgName>
								<orgName type="institution">LMU München</orgName>
								<address>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Local contact(s)</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">826490724639CAD3BB191C1410DC7681</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-05-23T15:44+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">unknown</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=1, consolidateHeader=1, consolidateFunders=0, includeRawAffiliations=false, includeRawCitations=true, includeRawCopyrights=false, generateTeiIds=false, generateTeiCoordinates=[], flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract/>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>PRELIMINARY REPORT</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction and aim of experiment:</head><p>The main aim of the conducted SAXS/WAXS study was to gain a more fundamental understanding of protein behavior in the freeze-concentrated (FC) state in terms of protein-protein interactions (PPI) and protein-protein distances (PPD). Both factors critically influence the colloidal stability of the protein and, as challenging to assess in the frozen state, are still of limited understanding. Expanding this knowledge and investigating the correlation to protein stability will enable a more rational formulation choice for frozen storage.</p><p>The main part of the assigned beamtime was dedicated to the analysis of isolated freeze concentrates and frozen aqueous formulations of a model monoclonal antibody (mAb). Formulations included different mAb: sucrose mass ratios and, at a set ratio, different ionic strengths, ion types, and pH values (Tab. 1). Sets of isolated and in-situ generated freeze concentrates were measured to assess if the direct determination of PPD and PPI would be possible in presence of ice interfaces. Furthermore, we attempted time-resolved SAXS/WAXS measurements during subzero temperatures to monitor potential changes in PPD and folding state to decouple temperature effects in the frozen state from formulation impact itself.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and Methods:</head><p>Dilute solutions (0.3-6 mg/ml mAb) for the analysis of P(q), describing single-particle properties, were obtained through the addition of ultrapure water to the freezing solutions and measured in the flow-through cell at RT to obtain exact background subtraction. At investigated concentrations, no interparticle interactions or aggregation have been observed (Fig. <ref type="figure" target="#fig_1">1</ref>-2) and a folded mAb is indicated by the Kratky plot (Fig. <ref type="figure" target="#fig_3">3</ref>).</p><p>Isolated FCs of the model mAb were produced by partial freeze-drying and moisture equilibration prior to measurements. For verification of the amorphous state of all components and the absence of potential crystallization of unbound water, combined SAXS/WAXS was used. Samples were cooled to -40°C on a LINKAM variable temperature stage. In-situ FCs were obtained by freezing the same solution as used for freeze drying to -40°C on the Linkam stage. Isolated FCs (75% total solid content) were measured between spaced glass coverslips, using sample cells (1.5mm layer thickness), and in-situ generated samples were filled to quartz capillaries (1 mm diameter). The first peak in the S(q) contribution corresponding to the nearest distance between interfering neighbors was monitored as a function of formulation composition. The peak position was fitted polynomially and the shoulder position was determined.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results and Conclusion:</head><p>Preliminary results, as evaluation is ongoing 1. Determination of PPD: A shoulder attributed to S(q), corresponding to the nearest neighbor distance, was observed at an identical q position in corresponding isolated and in-situ FC samples (Fig. <ref type="figure">4</ref>, exemplary: F02, q (Å -1 ) = . PPD thus could be determined in the presence of ice interfaces in the Linkam stage set-up. The shoulder became more distinct with increasing mAb content.</p><p>2. Impact of formulation on PPD: Formulation dependant changes of center-center distances in the FC could be observed. In the SAXS patterns of different mAb: sucrose mass ratios a q shift of the shoulder from q = 0.0923 Å -1 , d-spacing of 68 Å, to q = 0.1080 Å -1 , d-spacing of 58 Å, could be observed with decreasing ratio (Fig. <ref type="figure">5</ref><ref type="figure">6</ref>). Very slight changes were detected for different pH (Fig. <ref type="figure" target="#fig_5">7</ref><ref type="figure" target="#fig_6">8</ref>). For ionic strength and different salt types, no differences could be determined.</p><p>3. S(q)eff → S(0) analysis ongoing for net interaction behavior in FC and during upconcentration (dilution row of formulations at constant ratio).    0 2 0 4 0 6 0 8 0 1 0 0 1 2 0 1 4 0 1 6 0 0.000000 0.000002 0.000004 0.000006 0.000008 0.000010 P(r) r [Å] Pair distribution function 0 .0 0 0 2 0 .0 0 0 4 0 .0 0 0 6 0 .0 0 0 8 0 .0 0 1 0 0 .0 0 1 2 0 .0 0 1 4 -5.8 -5.6 -5.4 -5.2 -5.0 -4.8 ln (I[q]) q 2 [Å] F02 mAb:Suc 2:7 in 20 mM His -6 mg/ml Guinier analysis 0 5 1 0 1 5 2 0 -1.5 -1 -0.5 0 0.5 1 1.5 (qR g ) 2 *I(q)/I(0 qR g Kratky plot (dimensionless) 0.01 0.1 1E-5 1E-4 0 0.01 0.1 1 10 in situ FC F02 I(q)[sr-1]_ce12_eiger2_00132_00001_av_normq_sub_ave.h5_00001_[F02_LS_mAbSuc_2:7_ramp_-40||T_hot=-40_degC|sah=0|elev=0]_trm=0.654285 isolated FC F02 I(q)[sr-1]_ce12_eiger2_00012_av_sub_ave.h5_00001_[F02_cell||sah=0|elev=0]_trm=0.320160 polyfit frozen FC F02 polyfit in situ FC F02 I (q) q (Å -1 ) Figure 5. SAXS patterns of mAb: sucrose mass ratio variation. Figure 6. Region of interest and corresponding polynomial fits.  0.06 0.08 0.10 0.12 0.14 0.16 0.18 0.20 0.22 0.000 0.001 0.002 0.003 0.004 0.005 0.006 I (q) q (Å -1 ) I(q)[sr-1]_lqhq(ce12_eiger2_00132_00001_av_normq_sub_ave.h5_00001_[F02_LS_mAbSuc_2:7_ramp_-40])(lowlim=7.02E-01;highlim=2.00E+00) I(q)[sr-1]_lqhq(ce12_eiger2_00060_00010_av_normq_sub_ave.h5_00001_[F03_LS_cap_-40])(lowlim=7.00E-01;highlim=2.00E+00) I(q)[sr-1]_lqhq(ce12_eiger2_00062_00010_av_normq_sub_ave.h5_00001_[F04_LS_cap_-40])(lowlim=7.02E-01;highlim=2.00E+00) I(q)[sr-1]_lqhq(ce12_eiger2_00090_00001_av_normq_sub_ave.h5_00001_[F05_LS_Suc_5:7_cap_-40])(lowlim=7.02E-01;highlim=2.00E+00) I(q)[sr-1]_lqhq(ce12_eiger2_00092_00001_av_normq_sub_ave.h5_00001_[F06_LS_Suc_1:1_cap_-40])(lowlim=7.02E-01;highlim=2.00E+00) 0.01 0.02 0.1 0.2 1E-4 0 0.01 0.1 1 I(q)[sr-1]_ce12_eiger2_00092_00001_av_normq_sub_ave.h5_00001_[F06_LS_Suc_1:1_cap_-40||T_hot=-40_degC|sah=0|elev=0]_trm=0.675152 I(q)[sr-1]_ce12_eiger2_00090_00001_av_normq_sub_ave.h5_00001_[F05_LS_Suc_5:7_cap_-40||T_hot=-40_degC|sah=0|elev=0]_trm=0.658689 I(q)[sr-1]_ce12_eiger2_00062_00010_av_normq_sub_ave.h5_00001_[F04_LS_cap_-40||T_hot=-40_degC|sah=0|elev=0]_trm=0.670989 I(q)[sr-1]_ce12_eiger2_00060_00010_av_normq_sub_ave.h5_00001_[F03_LS_cap_-40||T_hot=-40_degC|sah=0|elev=0]_trm=0.658974 I(q)[sr-1]_ce12_eiger2_00132_00001_av_normq_sub_ave.h5_00001_[F02_LS_mAbSuc_2:7_ramp_-40||T_hot=-40_degC|sah=0|elev=0]_trm=0.654285 I (q) q (Å -1 ) 0.01 0.1 0.2 1E-4 0 0.01 0.1 1 10 I(q)[sr-1]_ce12_eiger2_00064_00010_av_normq_sub_ave.h5_00001_[F17_LSNB_4.5_-40||T_hot=-40_degC|sah=0|elev=0]_trm=0.650911 I(q)[sr-1]_ce12_eiger2_00074_00001_av_normq_sub_ave.h5_00001_[F18_LSNB_5.5_-40||T_hot=-40_degC|sah=0|elev=0]_trm=0.641150 I(q)[sr-1]_ce12_eiger2_00066_00010_av_normq_sub_ave.h5_00001_[F19_LSNB_6.5_-40||T_hot=-40_degC|sah=0|elev=0]_trm=0.511998 I(q)[sr-1]_ce12_eiger2_00076_00001_av_normq_sub_ave.h5_00001_[F20_LSNB_7.5_-40||T_hot=-40_degC|sah=0|elev=0]_trm=0.653199 I (q) q[nm-1] 0.1 0.2 1E-4 0 0.01 I(q)[sr-1]_ce12_eiger2_00064_00010_av_normq_sub_ave.h5_00001_[F17_LSNB_4.5_-40||T_hot=-40_degC|sah=0|elev=0]_trm=0.650911 I(q)[sr-1]_ce12_eiger2_00074_00001_av_normq_sub_ave.h5_00001_[F18_LSNB_5.5_-40||T_hot=-40_degC|sah=0|elev=0]_trm=0.641150 I(q)[sr-1]_ce12_eiger2_00066_00010_av_normq_sub_ave.h5_00001_[F19_LSNB_6.5_-40||T_hot=-40_degC|sah=0|elev=0]_trm=0.511998 I(q)[sr-1]_ce12_eiger2_00076_00001_av_normq_sub_ave.h5_00001_[F20_LSNB_7.5_-40||T_hot=-40_degC|sah=0|elev=0]_trm=0.653199 polyfit pH 7.5 polyfit pH 6.5 polyfit pH 6.5 polyfit pH 7.5 I (q)</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Figures and tables:</head><p>q (A -1 )</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><figDesc>SAXS study on protein-protein interactions in freeze concentrates on understanding the impact of formulation and temperature during freezing and frozen storage of biologics</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 1 .</head><label>1</label><figDesc>Figure 1. Guinier plot and fit of diluted freezing solution F02 (6 mg/ml mAb).</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 2 .</head><label>2</label><figDesc>Figure 2. P(r) distribution of diluted freezing solution F02.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 3 .</head><label>3</label><figDesc>Figure 3. Kratky plot of diluted freezing solution F02, showing a typical curve for a flexible, multidomain but folded antibody structure.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Figure 4 .Figure 5 .Figure 6 .</head><label>456</label><figDesc>Figure 4. SAXS patterns of in-situ generated and isolated FC of F02.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Figure 7 .</head><label>7</label><figDesc>Figure 7. SAXS patterns of pH variation [4.5 to 7.5] at a constant mAb: sucrose ratio [2:7].</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>Figure 8 .</head><label>8</label><figDesc>Figure 8. Region of interest and corresponding polynomial fits.</figDesc></figure>
		</body>
		<back>
			<div type="references">

				<listBibl/>
			</div>
		</back>
	</text>
</TEI>
